Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meenakshi Hegde

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Frontiers in Oncology|December 16, 2014
Human cytomegalovirus antigens in malignant gliomas as targets for adoptive cellular therapyDaniel Landi, Meenakshi Hegde, Nabil Ahmed
Discovery Medicine|March 20, 2014
Novel approaches and mechanisms of immunotherapy for glioblastomaMeenakshi Hegde, Kevin J Bielamowicz, Nabil Ahmed
Cytotherapy|August 2, 2014
Cellular immunotherapy for pediatric solid tumorsMeenakshi Hegde, Alexander J Moll, Tiara T Byrd, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|July 24, 2015
Polystyrene microspheres enable 10-color compensation for immunophenotyping of primary human leukocytesTiara Byrd, Karen D Carr, John C Norman, et al.
Cytotherapy|May 21, 2014
T cells redirected to interleukin-13Rα2 with interleukin-13 mutein--chimeric antigen receptors have anti-glioma activity but also recognize interleukin-13Rα1Simone Krebs, Kevin K H Chow, Zhongzhen Yi, et al.
Head & Neck|March 4, 2021
Human epidermal growth factor receptor 2 expression in head and neck squamous cell carcinoma: Variation within and across primary tumor sites, and implications for antigen-specific immunotherapyEmilie A K Warren, Joshua Anil, Patricia D Castro, et al.
Neuro-Oncology|September 11, 2019
Immunotherapy for pediatric brain tumors: past and presentJessica B Foster, Peter J Madsen, Meenakshi Hegde, et al.
Journal of Neuro-Oncology|September 6, 2015
Is CMV a target in pediatric glioblastoma? Expression of CMV proteins, pp65 and IE1-72 and CMV nucleic acids in a cohort of pediatric glioblastoma patientsAmanda Wakefield, Antonella Pignata, Alexia Ghazi, et al.
Neuro-Oncology|October 11, 2017
Trivalent CAR T cells overcome interpatient antigenic variability in glioblastomaKevin Bielamowicz, Kristen Fousek, Tiara T Byrd, et al.
Nature Reviews. Clinical Oncology|February 26, 2021
Immunogenicity of CAR T cells in cancer therapyDimitrios L Wagner, Enrico Fritsche, Michael A Pulsipher, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|December 16, 2014
Human cytomegalovirus antigens in malignant gliomas as targets for adoptive cellular therapyDaniel Landi, Meenakshi Hegde, Nabil Ahmed
Discovery Medicine|March 20, 2014
Novel approaches and mechanisms of immunotherapy for glioblastomaMeenakshi Hegde, Kevin J Bielamowicz, Nabil Ahmed
Cytotherapy|August 2, 2014
Cellular immunotherapy for pediatric solid tumorsMeenakshi Hegde, Alexander J Moll, Tiara T Byrd, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|July 24, 2015
Polystyrene microspheres enable 10-color compensation for immunophenotyping of primary human leukocytesTiara Byrd, Karen D Carr, John C Norman, et al.
Cytotherapy|May 21, 2014
T cells redirected to interleukin-13Rα2 with interleukin-13 mutein--chimeric antigen receptors have anti-glioma activity but also recognize interleukin-13Rα1Simone Krebs, Kevin K H Chow, Zhongzhen Yi, et al.
Head & Neck|March 4, 2021
Human epidermal growth factor receptor 2 expression in head and neck squamous cell carcinoma: Variation within and across primary tumor sites, and implications for antigen-specific immunotherapyEmilie A K Warren, Joshua Anil, Patricia D Castro, et al.
Neuro-Oncology|September 11, 2019
Immunotherapy for pediatric brain tumors: past and presentJessica B Foster, Peter J Madsen, Meenakshi Hegde, et al.
Journal of Neuro-Oncology|September 6, 2015
Is CMV a target in pediatric glioblastoma? Expression of CMV proteins, pp65 and IE1-72 and CMV nucleic acids in a cohort of pediatric glioblastoma patientsAmanda Wakefield, Antonella Pignata, Alexia Ghazi, et al.
Neuro-Oncology|October 11, 2017
Trivalent CAR T cells overcome interpatient antigenic variability in glioblastomaKevin Bielamowicz, Kristen Fousek, Tiara T Byrd, et al.
Nature Reviews. Clinical Oncology|February 26, 2021
Immunogenicity of CAR T cells in cancer therapyDimitrios L Wagner, Enrico Fritsche, Michael A Pulsipher, et al.
Pageof 4